(1)
LeBlanc, R.; Hollmann, S.; Tay, J. CANADIAN COST ANALYSIS COMPARING MAINTENANCE THERAPY WITH BORTEZOMIB VERSUS LENALIDOMIDE FOR PATIENTS WITH MULTIPLE MYELOMA POST AUTOLOGOUS STEM CELL TRANSPLANT. J Popl Ther Clin Pharmacol 2018, 23.